Literature DB >> 19184066

[Wegener's granulomatosis and microscopic polyangiitis].

K de Groot1, E Reinhold-Keller.   

Abstract

Wegener's granulomatosis (WG) and microscopic polyangiitis (MPA) are primary systemic small vessel vasculitides, associated with a positive C/PR3-ANCA in WG and P/MPO-ANCA in MPA. The most prominently involved organs are the upper (only in WG) and lower respiratory tract and the kidneys. The diagnostic work-up is an interdisciplinary approach assessing disease stage and extent. Treatment is adapted to disease stage and extent and relies on a combination of a cytotoxic plus a tapering regimen of corticosteroids. Induction of remission in "early systemic" disease can be achieved with low-dose methotrexate. In severe generalized vasculitis cyclophosphamide (CYC) is the mainstay of therapy, in rapidly progressive glomerulonephritis in combination with plasmapheresis. After 3-6 months of induction CYC is switched to a maintenance treatment with azathioprine. Alternatives are leflunomide, mycophenolate or methotrexate (creatinine < 150 micromol/l). Age > or = 50 at diagnosis, renal dysfunction and pulmonary involvement are associated with higher mortality rates. The relapse rate is approximately 50% within 5 years, being higher in WG than MPA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184066     DOI: 10.1007/s00393-008-0425-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  90 in total

1.  Active disease and residual damage in treated Wegener's granulomatosis: an observational study using pulmonary high-resolution computed tomography.

Authors:  András Komócsi; Michael Reuter; Martin Heller; Henriette Muraközi; Wolfgang L Gross; Armin Schnabel
Journal:  Eur Radiol       Date:  2002-05-16       Impact factor: 5.315

Review 2.  Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.

Authors:  P Lamprecht
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

Authors:  K Raza; D M Carruthers; R Stevens; A D Filer; J N Townend; P A Bacon
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

4.  Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

Authors:  Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; E Christiaan Hagen; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 10.121

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

7.  Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

Authors:  Loïc Guillevin; Pascal Cohen; Alfred Mahr; Jean-Pierre Arène; Luc Mouthon; Xavier Puéchal; Edouard Pertuiset; Brigitte Gilson; Mohamed Hamidou; Patricia Lanoux; Alain Bruet; Marc Ruivard; Philippe Vanhille; Jean-François Cordier
Journal:  Arthritis Rheum       Date:  2003-02-15

Review 8.  Pathogenesis of Wegener's granulomatosis.

Authors:  W L Gross; A Trabandt; E Csernok
Journal:  Ann Med Interne (Paris)       Date:  1998-09

9.  Membrane proteinase 3 expression and ANCA-induced neutrophil activation.

Authors:  Adrian Schreiber; Friedrich C Luft; Ralph Kettritz
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

10.  Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo.

Authors:  Heiko Pfister; Markus Ollert; Leopold F Fröhlich; Leticia Quintanilla-Martinez; Thomas V Colby; Ulrich Specks; Dieter E Jenne
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

View more
  2 in total

1.  Granulomatosis with polyangiitis (Wegener's granulomatosis): a rare variant of sudden natural death.

Authors:  Birthe Heitkötter; Cornelius Kuhnen; Sven Schmidt; Daniel Wittschieber
Journal:  Int J Legal Med       Date:  2017-10-31       Impact factor: 2.686

2.  Nasal surgery in patients with systemic disorders.

Authors:  Florian Sachse; Wolfgang Stoll
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.